Literature DB >> 24361629

Improved access to early infant diagnosis is a critical part of a child-centric prevention of mother-to-child transmission agenda.

Anisa Ghadrshenas1, Yanis Ben Amor, Joy Chang, Helen Dale, Gayle Sherman, Lara Vojnov, Paul Young, Ram Yogev.   

Abstract

BACKGROUND: Prevention-of-mother-to-child-transmission (PMTCT) programs have made it possible to achieve dramatic reductions in the rate of vertical HIV transmission. However, high attrition, particularly after delivery, has limited the impact of these interventions for HIV-exposed infants who remain at risk through the end of breastfeeding. DESIGN AND METHODS: A review of current literature on early infant diagnosis (EID) testing and country experience in low-and middle-income countries.
RESULTS: While PMTCT programs report reduced rates of infection among infants tested at 2 months of age, too few services are focused on retention of HIV-exposed infants in care. An unacceptably large proportion of HIV-exposed and HIV-infected infants remain unidentified. While the complexities of EID have been simplified with the development of optimized commodities and tools to improve service delivery, the inaccessibility and inadequate uptake of EID services has resulted in lag of care for the millions of HIV-exposed infants who remain unidentified. Coverage of EID testing remains low and there are many HIV- infected infants or at risk of infection who may not enter the health system through PMTCT programs. Waiting for HIV-infected children to present sick is not an adequate strategy for identifying and linking infants to treatment. Several interventions suggest a potential to expand access to EID testing, while more aggressive testing strategies may ensure children can be captured at any point of contact with the health system.
CONCLUSIONS: Programs focused on preventing vertical transmission need to increase their commitment to child-centric interventions and broaden their measure of success to reflect infants who test negative at the end of the exposure period. This paper argues that EID is a key strategy to retaining HIV-exposed infants through the end of the exposure period, as it provides an opportunity to offer early clinical care and continuous follow up. It is imperative that maternal and child survival programs become sensitized to the urgency of early identification of HIV in infants and their retention in care.

Entities:  

Mesh:

Year:  2013        PMID: 24361629     DOI: 10.1097/QAD.0000000000000104

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  24 in total

Review 1.  A lifecycle approach to HIV prevention in African women and children.

Authors:  Alison C Roxby; Jennifer A Unger; Jennifer A Slyker; John Kinuthia; Andrew Lewis; Grace John-Stewart; Judd L Walson
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

2.  Correlates of suboptimal entry into early infant diagnosis in rural north central Nigeria.

Authors:  Muktar H Aliyu; Meridith Blevins; Karen M Megazzini; Carolyn M Audet; Julie Dunlap; Ibrahim S Sodangi; Usman I Gebi; Bryan E Shepherd; C William Wester; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

3.  "I just wish that everything is in one place": facilitators and barriers to continuity of care among HIV-positive, postpartum women with a non-communicable disease in South Africa.

Authors:  Kate Clouse; Molebogeng Motlhatlhedi; Kemberlee Bonnet; David Schlundt; David M Aronoff; Rosette Chakkalakal; Shane A Norris
Journal:  AIDS Care       Date:  2018-05-30

4.  Consolidating HIV testing in a public health laboratory for efficient and sustainable early infant diagnosis (EID) in Uganda.

Authors:  Charles Kiyaga; Hakim Sendagire; Eleanor Joseph; Jeff Grosz; Ian McConnell; Vijay Narayan; Godfrey Esiru; Peter Elyanu; Zainab Akol; Wilford Kirungi; Joshua Musinguzi; Alex Opio
Journal:  J Public Health Policy       Date:  2015-03-26       Impact factor: 2.222

5.  Rapid Serological Tests Ineffectively Screen for HIV Exposure in HIV-Positive Infants.

Authors:  Brittany Urick; Youyi Fong; Christopher Okiira; Nicolette Nabukeera-Barungi; Denis Nansera; Emmanuel Ochola; Julius Nteziyaremye; Victor Bigira; Isaac Ssewanyana; Peter Olupot-Olupot; Trevor Peter; Anisa Ghadrshenas; Lara Vojnov; Charles Kiyaga
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

6.  Implementation and Operational Research: Impact of a Systems Engineering Intervention on PMTCT Service Delivery in Côte d'Ivoire, Kenya, Mozambique: A Cluster Randomized Trial.

Authors:  Alison Silvis Rustagi; Sarah Gimbel; Ruth Nduati; Maria de Fatima Cuembelo; Judith N Wasserheit; Carey Farquhar; Stephen Gloyd; Kenneth Sherr
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

7.  Active tracking of rejected dried blood samples in a large program in Nigeria.

Authors:  Auchi Inalegwu; Sunny Phillips; Rawlings Datir; Christopher Chime; Petronilla Ozumba; Samuel Peters; Obinna Ogbanufe; Charles Mensah; Alash'Le Abimiku; Patrick Dakum; Nicaise Ndembi
Journal:  World J Virol       Date:  2016-05-12

8.  Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist Among HIV-infected Infants and Young Children.

Authors:  Elaine J Abrams; Selamawit Woldesenbet; Juliana Soares Silva; Ashraf Coovadia; Viviane Black; Karl-Günter Technau; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2017-06       Impact factor: 2.129

9.  Cross-subtype detection of HIV-1 using reverse transcription and recombinase polymerase amplification.

Authors:  Lorraine Lillis; Dara A Lehman; Joshua B Siverson; Julie Weis; Jason Cantera; Mathew Parker; Olaf Piepenburg; Julie Overbaugh; David S Boyle
Journal:  J Virol Methods       Date:  2016-01-25       Impact factor: 2.014

10.  Early infant HIV diagnosis and entry to HIV care cascade in Thailand: an observational study.

Authors:  Wasna Sirirungsi; Woottichai Khamduang; Intira Jeannie Collins; Artit Pusamang; Pranee Leechanachai; Suchada Chaivooth; Nicole Ngo-Giang-Huong; Tanawan Samleerat
Journal:  Lancet HIV       Date:  2016-05-03       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.